Cargando…
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
BACKGROUND: Patients with non-small cell lung cancer (NSCLC) harboring a ROS proto-oncogene 1 (ROS1)-rearrangement respond to treatment with ROS1 inhibitors. To distinguish these rare cases, screening with immunohistochemistry (IHC) for ROS1 protein expression has been suggested. However, the reliab...
Autores principales: | Thurfjell, Viktoria, Micke, Patrick, Yu, Hui, Krupar, Rosemarie, Svensson, Maria A., Brunnström, Hans, Lamberg, Kristina, Moens, Lotte N. J., Strell, Carina, Gulyas, Miklos, Helenius, Gisela, Yoshida, Akihiko, Goldmann, Torsten, Mattsson, Johanna Sofia Margareta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830269/ https://www.ncbi.nlm.nih.gov/pubmed/36636421 http://dx.doi.org/10.21037/tlcr-22-504 |
Ejemplares similares
-
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
por: Goldmann, Torsten, et al.
Publicado: (2021) -
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
por: Mattsson, Johanna S. M., et al.
Publicado: (2016) -
TGF-β-mediated epithelial–mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
por: Miyashita, Naoya, et al.
Publicado: (2021) -
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
por: Micke, Patrick, et al.
Publicado: (2019) -
Mouse Model for ROS1-Rearranged Lung Cancer
por: Arai, Yasuhito, et al.
Publicado: (2013)